Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Fluconazole | hsa00052 | Galactose metabolism | 1.03E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Fluconazole | hsa00500 | Starch and sucrose metabolism | 1.67E-02 | 2 | O43451, P06737 | MGAM, PYGL | More | | Fluconazole | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Fluconazole | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | | Fluconazole | hsa00630 | Glyoxylate and dicarboxylate metabolism | 1.32E-02 | 2 | P40925, P15104 | MDH1, GLUL | More | | Fluconazole | hsa00730 | Thiamine metabolism | 5.29E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Fluconazole | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-03 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Fluconazole | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | | Fluconazole | hsa00983 | Drug metabolism - other enzymes | 2.44E-02 | 2 | P32320, P05164 | CDA, MPO | More | | Fluconazole | hsa03040 | Spliceosome | 4.19E-04 | 10 | Q14562, O43143, O60508, P08579, Q07955, Q01130, Q13243, P11142, O43447, O75643 | DHX8, DHX15, CDC40, SNRPB2, SFRS1, SFRS2, SFRS5, HSPA8, PPIH, ASCC3L1 | More | | Fluconazole | hsa04012 | ErbB signaling pathway | 1.34E-02 | 4 | P16333, P19174, P42338, P01106 | NCK1, PLCG1, PIK3CB, MYC | More | | Fluconazole | hsa04014 | Ras signaling pathway | 2.92E-04 | 10 | P42338, P20827, Q9NRA1, P49767, Q13009, P0DP23, P62873, P63218, P50151, P19174 | PIK3CB, EFNA1, PDGFC, VEGFC, TIAM1, CALM1, GNB1, GNG5, GNG10, PLCG1 | More | | Fluconazole | hsa04015 | Rap1 signaling pathway | 4.83E-03 | 8 | P20827, Q9NRA1, P49767, P11215, Q13009, P42338, P0DP23, P19174 | EFNA1, PDGFC, VEGFC, ITGAM, TIAM1, PIK3CB, CALM1, PLCG1 | More | | Fluconazole | hsa04020 | Calcium signaling pathway | 2.61E-02 | 6 | P27987, P21796, P19174, P0DP23, Q9NRA1, P49767 | ITPKB, VDAC1, PLCG1, CALM1, PDGFC, VEGFC | More | | Fluconazole | hsa04062 | Chemokine signaling pathway | 3.26E-04 | 11 | P07948, P42338, P19174, P62873, P63218, P50151, P43250, Q13009, P14598, P42224, P25963 | LYN, PIK3CB, PLCG1, GNB1, GNG5, GNG10, GRK6, TIAM1, NCF1, STAT1, NFKBIA | More | | Fluconazole | hsa04070 | Phosphatidylinositol signaling system | 1.12E-02 | 5 | P19174, P0DP23, P42338, P23743, P27987 | PLCG1, CALM1, PIK3CB, DGKA, ITPKB | More | | Fluconazole | hsa04071 | Sphingolipid signaling pathway | 1.94E-02 | 3 | Q9H228, P01375, Q9UQC2 | EDG8, TNF, GAB2 | More | | Fluconazole | hsa04072 | Phospholipase D signaling pathway | 4.67E-02 | 5 | P42338, P19174, Q14344, P23743, Q9NRA1 | PIK3CB, PLCG1, GNA13, DGKA, PDGFC | More | | Fluconazole | hsa04114 | Oocyte meiosis | 1.33E-02 | 4 | P51812, Q02750, P16298, Q17RY0 | RPS6KA3, MAP2K1, PPP3CB, CPEB4 | More | | Fluconazole | hsa04150 | mTOR signaling pathway | 3.60E-02 | 3 | Q02750, Q9NQL2, P51812 | MAP2K1, RRAGD, RPS6KA3 | More | | Fluconazole | hsa04151 | PI3K-Akt signaling pathway | 5.62E-03 | 12 | P42338, P01106, P20827, Q9NRA1, P49767, P08238, P62873, P63218, P50151, O15335, P14784, P01568 | PIK3CB, MYC, EFNA1, PDGFC, VEGFC, HSP90AB1, GNB1, GNG5, GNG10, CHAD, IL2RB, IFNA21 | More | | Fluconazole | hsa04210 | Apoptosis | 3.58E-02 | 4 | O76075, P01375, Q9NR28, Q16548 | DFFB, TNF, DIABLO, BCL2A1 | More | | Fluconazole | hsa04211 | Longevity regulating pathway | 3.63E-02 | 3 | Q08828, Q99941, Q96RR4 | ADCY1, CREBL1, CAMKK2 | More | | Fluconazole | hsa04270 | Vascular smooth muscle contraction | 8.93E-03 | 4 | P0DP24, Q08828, P35579, P35318 | CALM2, ADCY1, MYH9, ADM | More | | Fluconazole | hsa04340 | Hedgehog signaling pathway | 3.32E-02 | 2 | P49841, P22694 | GSK3B, PRKACB | More | | Fluconazole | hsa04360 | Axon guidance | 2.87E-02 | 5 | P16333, P20827, O95631, P42338, P19174 | NCK1, EFNA1, NTN1, PIK3CB, PLCG1 | More | | Fluconazole | hsa04370 | VEGF signaling pathway | 2.68E-03 | 3 | P16298, Q05397, Q02750 | PPP3CB, PTK2, MAP2K1 | More | | Fluconazole | hsa04371 | Apelin signaling pathway | 2.41E-03 | 7 | P62873, P63218, P50151, Q13370, Q14814, Q14344, P0DP23 | GNB1, GNG5, GNG10, PDE3B, MEF2D, GNA13, CALM1 | More | | Fluconazole | hsa04530 | Tight junction | 3.29E-02 | 3 | P16989, P56750, Q14247 | CSDA, CLDN17, CTTN | More | | Fluconazole | hsa04613 | Neutrophil extracellular trap formation | 2.06E-03 | 11 | P42338, P19174, P11215, Q13547, Q93077, P62807, Q93079, O60814, P68431, P21796, P14598 | PIK3CB, PLCG1, ITGAM, HDAC1, HIST1H2AC, HIST1H2BC, H2BC9, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, VDAC1, NCF1 | More | | Fluconazole | hsa04620 | Toll-like receptor signaling pathway | 4.00E-02 | 4 | P01568, P42224, P25963, P42338 | IFNA21, STAT1, NFKBIA, PIK3CB | More | | Fluconazole | hsa04623 | Cytosolic DNA-sensing pathway | 3.67E-02 | 2 | P01568, P25963 | IFNA21, NFKBIA | More | | Fluconazole | hsa04625 | C-type lectin receptor signaling pathway | 2.17E-02 | 5 | Q9ULY5, P42224, P25963, P42338, P0DP23 | CLEC4E, STAT1, NFKBIA, PIK3CB, CALM1 | More | | Fluconazole | hsa04650 | Natural killer cell mediated cytotoxicity | 2.94E-02 | 3 | P16298, P50591, Q02750 | PPP3CB, TNFSF10, MAP2K1 | More | | Fluconazole | hsa04657 | IL-17 signaling pathway | 3.31E-02 | 3 | P49841, P14780, P01375 | GSK3B, MMP9, TNF | More | | Fluconazole | hsa04658 | Th1 and Th2 cell differentiation | 8.74E-03 | 6 | P25963, P07766, P19174, P42224, P14784, Q13761 | NFKBIA, CD3E, PLCG1, STAT1, IL2RB, RUNX3 | More | | Fluconazole | hsa04659 | Th17 cell differentiation | 2.61E-02 | 6 | P25963, P19174, P42224, P14784, P08238, P07766 | NFKBIA, PLCG1, STAT1, IL2RB, HSP90AB1, CD3E | More | | Fluconazole | hsa04662 | B cell receptor signaling pathway | 1.12E-02 | 5 | P25963, P42338, P07948, P21854, Q8N149 | NFKBIA, PIK3CB, LYN, CD72, LILRA2 | More | | Fluconazole | hsa04664 | Fc epsilon RI signaling pathway | 1.34E-02 | 4 | P42338, P07948, P19174, P09917 | PIK3CB, LYN, PLCG1, ALOX5 | More | | Fluconazole | hsa04666 | Fc gamma R-mediated phagocytosis | 2.92E-02 | 4 | P07948, P42338, P19174, P14598 | LYN, PIK3CB, PLCG1, NCF1 | More | | Fluconazole | hsa04713 | Circadian entrainment | 4.00E-02 | 4 | P0DP23, P62873, P63218, P50151 | CALM1, GNB1, GNG5, GNG10 | More | | Fluconazole | hsa04720 | Long-term potentiation | 1.38E-02 | 3 | P16298, P51812, Q02750 | PPP3CB, RPS6KA3, MAP2K1 | More | | Fluconazole | hsa04724 | Glutamatergic synapse | 2.92E-02 | 4 | P62873, P63218, P50151, P15104 | GNB1, GNG5, GNG10, GLUL | More | | Fluconazole | hsa04725 | Cholinergic synapse | 2.92E-02 | 4 | P62873, P63218, P50151, P42338 | GNB1, GNG5, GNG10, PIK3CB | More | | Fluconazole | hsa04727 | GABAergic synapse | 8.14E-03 | 4 | P62873, P63218, P50151, P15104 | GNB1, GNG5, GNG10, GLUL | More | | Fluconazole | hsa04744 | Phototransduction | 1.32E-02 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Fluconazole | hsa04750 | Inflammatory mediator regulation of TRP channels | 4.00E-02 | 4 | P19174, P42338, P24723, P0DP23 | PLCG1, PIK3CB, PRKCH, CALM1 | More | | Fluconazole | hsa04810 | Regulation of actin cytoskeleton | 2.61E-02 | 6 | P12814, Q13009, P42338, P11215, Q14344, Q9NRA1 | ACTN1, TIAM1, PIK3CB, ITGAM, GNA13, PDGFC | More | | Fluconazole | hsa04910 | Insulin signaling pathway | 2.35E-02 | 3 | P22694, P06737, P49841 | PRKACB, PYGL, GSK3B | More | | Fluconazole | hsa04914 | Progesterone-mediated oocyte maturation | 4.29E-03 | 7 | Q17RY0, P42338, Q13370, P30304, P08238, P51812, Q02750 | CPEB4, PIK3CB, PDE3B, CDC25A, HSP90AB1, RPS6KA3, MAP2K1 | More | | Fluconazole | hsa04919 | Thyroid hormone signaling pathway | 7.11E-03 | 4 | P49841, P22694, O60244, Q9NVC6 | GSK3B, PRKACB, MED14, MED17 | More | | Fluconazole | hsa04925 | Aldosterone synthesis and secretion | 2.27E-02 | 3 | Q99941, Q08828, P0DP24 | CREBL1, ADCY1, CALM2 | More | | Fluconazole | hsa04926 | Relaxin signaling pathway | 8.74E-03 | 6 | P25963, P42338, P62873, P63218, P50151, P49767 | NFKBIA, PIK3CB, GNB1, GNG5, GNG10, VEGFC | More | | Fluconazole | hsa04931 | Insulin resistance | 1.94E-02 | 3 | P01375, P49841, P06737 | TNF, GSK3B, PYGL | More | | Fluconazole | hsa04976 | Bile secretion | 2.44E-02 | 2 | P22694, P08183 | PRKACB, ABCB1 | More | | Fluconazole | hsa05012 | Parkinson disease | 4.01E-02 | 6 | P21796, P60604, P19174, P0DP23, Q71U36, Q13509 | VDAC1, UBE2G2, PLCG1, CALM1, TUBA1A, TUBB3 | More | | Fluconazole | hsa05032 | Morphine addiction | 7.60E-03 | 5 | P62873, P63218, P50151, Q13370, P43250 | GNB1, GNG5, GNG10, PDE3B, GRK6 | More | | Fluconazole | hsa05034 | Alcoholism | 9.92E-05 | 10 | Q13547, P0DP23, P62873, P63218, P50151, Q93077, P62807, Q93079, O60814, P68431 | HDAC1, CALM1, GNB1, GNG5, GNG10, HIST1H2AC, HIST1H2BC, H2BC9, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Fluconazole | hsa05132 | Salmonella infection | 2.36E-02 | 8 | P25963, P08238, P01106, P42338, O75369, Q71U36, Q13509, P49754 | NFKBIA, HSP90AB1, MYC, PIK3CB, FLNB, TUBA1A, TUBB3, VPS41 | More | | Fluconazole | hsa05162 | Measles | 1.84E-02 | 7 | P01568, P25963, P42224, P14784, P07766, P42338, P11142 | IFNA21, NFKBIA, STAT1, IL2RB, CD3E, PIK3CB, HSPA8 | More | | Fluconazole | hsa05163 | Human cytomegalovirus infection | 9.45E-05 | 15 | P42338, P25963, P62873, P63218, P50151, P0DP23, P0DP24, Q14344, Q08828, P23458, P01106, P61073, Q99941, P30101, P01568 | PIK3CB, NFKBIA, GNB1, GNG5, GNG10, CALM1, CALM2, GNA13, ADCY1, JAK1, MYC, CXCR4, CREBL1, PDIA3, IFNA21 | More | | Fluconazole | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 4.21E-06 | 15 | P01568, P42224, P25963, P42338, P62873, P62879, P63218, P50151, P19174, P16298, Q02750, P07948, P01106, P0DP23, P0CG47 | IFNA21, STAT1, NFKBIA, PIK3CB, GNB1, GNB2, GNG5, GNG10, PLCG1, PPP3CB, MAP2K1, LYN, MYC, CALM1, UBB | More | | Fluconazole | hsa05168 | Herpes simplex virus 1 infection | 4.57E-02 | 10 | P25963, P01568, P42224, Q07955, Q01130, Q13243, P30101, P42338, Q13398, O75820 | NFKBIA, IFNA21, STAT1, SFRS1, SFRS2, SFRS5, PDIA3, PIK3CB, ZNF211, ZNF189 | More | | Fluconazole | hsa05169 | Epstein-Barr virus infection | 1.08E-03 | 11 | P01106, Q13547, P25963, P42338, P07948, P30101, Q13761, O75293, P42224, P01568, P07766 | MYC, HDAC1, NFKBIA, PIK3CB, LYN, PDIA3, RUNX3, GADD45B, STAT1, IFNA21, CD3E | More | | Fluconazole | hsa05170 | Human immunodeficiency virus 1 infection | 5.72E-05 | 15 | P42338, Q02750, P62873, P62879, P63218, P50151, P16298, P0DP23, Q05397, P30101, P01568, P25963, P19174, P07766, P20333 | PIK3CB, MAP2K1, GNB1, GNB2, GNG5, GNG10, PPP3CB, CALM1, PTK2, PDIA3, IFNA21, NFKBIA, PLCG1, CD3E, TNFRSF1B | More | | Fluconazole | hsa05200 | Pathways in cancer | 1.82E-03 | 17 | P42338, P08238, P42224, P25963, P19174, P01106, P43246, Q13547, P49767, P62873, P63218, P50151, Q14344, O75293, P0DP23, P01568, P14784 | PIK3CB, HSP90AB1, STAT1, NFKBIA, PLCG1, MYC, MSH2, HDAC1, VEGFC, GNB1, GNG5, GNG10, GNA13, GADD45B, CALM1, IFNA21, IL2RB | More | | Fluconazole | hsa05203 | Viral carcinogenesis | 6.72E-04 | 11 | P42338, P06746, P07948, P29083, Q13547, Q15283, P12814, P25963, P62807, Q93079, O60814 | PIK3CB, POLB, LYN, GTF2E1, HDAC1, RASA2, ACTN1, NFKBIA, HIST1H2BC, H2BC9, H2BC12 | More | | Fluconazole | hsa05204 | Chemical carcinogenesis | 1.48E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Fluconazole | hsa05206 | MicroRNAs in cancer | 2.79E-02 | 7 | P30304, P09493, P01106, P42338, Q13547, P20827, P19174 | CDC25A, TPM1, MYC, PIK3CB, HDAC1, EFNA1, PLCG1 | More | | Fluconazole | hsa05213 | Endometrial cancer | 3.79E-02 | 2 | O15169, Q02750 | AXIN1, MAP2K1 | More | | Fluconazole | hsa05214 | Glioma | 1.34E-02 | 4 | P0DP23, P42338, P19174, O75293 | CALM1, PIK3CB, PLCG1, GADD45B | More | | Fluconazole | hsa05218 | Melanoma | 2.31E-02 | 3 | Q9NRA1, P42338, O75293 | PDGFC, PIK3CB, GADD45B | More | | Fluconazole | hsa05220 | Chronic myeloid leukemia | 2.17E-02 | 5 | Q13547, P01106, P25963, P42338, O75293 | HDAC1, MYC, NFKBIA, PIK3CB, GADD45B | More | | Fluconazole | hsa05226 | Gastric cancer | 3.79E-02 | 2 | Q02750, O15169 | MAP2K1, AXIN1 | More | | Fluconazole | hsa05231 | Choline metabolism in cancer | 2.92E-03 | 5 | P42338, Q9NRA1, Q9Y259, P19174, P23743 | PIK3CB, PDGFC, CHKB, PLCG1, DGKA | More | | Fluconazole | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 3.71E-02 | 5 | P25963, P42338, P19174, P07766, P42224 | NFKBIA, PIK3CB, PLCG1, CD3E, STAT1 | More | | Fluconazole | hsa05322 | Systemic lupus erythematosus | 1.31E-04 | 5 | P09871, Q93077, P62807, O60814, P68431 | C1S, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | |